Newsletter | November 16, 2026

11.16.26 -- STREAM: The Future Of Drug Manufacturing

A Smarter Microbial Approach To Therapeutic Peptide Manufacturing

Webinar | KBI Biopharma

See how microbial expression can improve therapeutic peptide yields, reduce costs, and simplify downstream processing while supporting development from research through manufacturing.

Spray Dried Biologics For OSD Dosage Forms

Webinar | Upperton Pharma Solutions

A fireside chat explores spray drying basics, oral biologic dosage forms, formulation hurdles, and testing strategies to ensure drug product quality, safety, and performance.

Bringing Cell Therapies To Patients Faster

Video | AGC Biologics

Scale cell therapies efficiently by adopting automated, closed systems and advanced analytical testing to reduce contamination risks, ensure regulatory compliance, and secure global patient supply.

Exploring The Cleanroom Rental Alternative

Video | Outsourced Pharma

This segment of the Outsourced Pharma Live event, "One Program Many CDMOs: Managing Multi-Partner Strategies," addresses alternative strategies for sponsors who want to keep manufacturing internal without the massive capital expense of building a full GMP facility.

Scaling Small Molecule Therapies With Integrated Drug Product Expertise

Video | Rottendorf Pharma GmbH

Optimize oral solid dose development with scalable formulations, robust process engineering, and integrated supply networks that accelerate scale-up and ensure reliable market delivery.

Process Development For CGT: How Soon Is Too Soon?

Webinar | Lonza

Deciding when cell and gene therapy programs should commit to process development, and how early choices shape commercial readiness, is a question industry leaders examine from several different vantage points.

The Next Evolution In Advanced Biomanufacturing

Video | Future Fields

Alternative expression platforms utilizing genetically engineered insect strains help overcome traditional manufacturing bottlenecks, offering organizations enhanced scalability, improved operational flexibility, and reliable long-term production consistency for complex protein targets.

Connect With Outsourced Pharma: